These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15516741)

  • 1. Dai-kenchu-to raises levels of calcitonin gene-related peptide and substance P in human plasma.
    Sato Y; Katagiri F; Inoue S; Itoh H; Takeyama M
    Biol Pharm Bull; 2004 Nov; 27(11):1875-7. PubMed ID: 15516741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Ninjin-to on levels of calcitonin gene-related peptide and substance P in human plasma.
    Sato Y; Katagiri F; Inoue S; Itoh H; Takeyama M
    Biol Pharm Bull; 2004 Dec; 27(12):2032-4. PubMed ID: 15577227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of hange-shashin-to and rikkunshi-to on human plasma calcitonin gene-related peptide and substance P levels.
    Naito T; Itoh H; Takeyama M
    Biol Pharm Bull; 2003 Aug; 26(8):1104-7. PubMed ID: 12913259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pirenzepine on Dai-kenchu-to-induced elevation of the plasma neuropeptide levels in humans.
    Sato Y; Inoue S; Katagiri F; Itoh H; Takeyama M
    Biol Pharm Bull; 2006 Jan; 29(1):166-71. PubMed ID: 16394532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Dai-kenchu-to on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma.
    Nagano T; Itoh H; Takeyama M
    Biol Pharm Bull; 1999 Oct; 22(10):1131-3. PubMed ID: 10549871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma.
    Katagiri F; Sato Y; Itoh H; Takeyama M
    J Pharm Pharmacol; 2004 Apr; 56(4):557-61. PubMed ID: 15099451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecabet sodium raises plasma levels of calcitonin generelated peptide and substance P in healthy humans.
    Katagiri F; Inoue S; Sato Y; Itoh H; Takeyama M
    J Pharm Pharmacol; 2005 Jun; 57(6):799-805. PubMed ID: 15969937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The herbal medicine Dai-kenchu-to and one of its active components [6]-shogaol increase intestinal blood flow in rats.
    Murata P; Kase Y; Ishige A; Sasaki H; Kurosawa S; Nakamura T
    Life Sci; 2002 Mar; 70(17):2061-70. PubMed ID: 12148698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Dai-kenchu-to on levels of 5-hydroxytryptamine (serotonin) and vasoactive intestinal peptides in human plasma.
    Nagano T; Itoh H; Takeyama M
    Biol Pharm Bull; 2000 Mar; 23(3):352-3. PubMed ID: 10726893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sho-hange-ka-bukuryo-to on gastrointestinal peptide concentrations in the plasma of healthy human subjects.
    Katagiri F; Itoh H; Takeyama M
    Biol Pharm Bull; 2004 Oct; 27(10):1674-8. PubMed ID: 15467218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma.
    Sato Y; Itoh H; Suzuki Y; Tatsuta R; Takeyama M
    J Clin Pharm Ther; 2013 Feb; 38(1):19-23. PubMed ID: 23030252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
    Itoh H; Naito T; Takeyama M
    J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of pantethine and fursultiamine on plasma gastrointestinal peptide levels in healthy volunteers.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    Biol Pharm Bull; 2011; 34(10):1640-3. PubMed ID: 21963510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensory nerve terminal activity in severe hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P.
    Edvinsson L; Erlinge D; Ekman R; Thulin T
    Blood Press; 1992 Dec; 1(4):223-9. PubMed ID: 1285370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man.
    Lind H; Brudin L; Lindholm L; Edvinsson L
    Clin Physiol; 1996 Jan; 16(1):73-82. PubMed ID: 8867778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of gamma-aminobutyric acid treatment on plasma substance P and calcitonin gene-related peptide levels in children with asthma].
    Xu CW; Guo SC; Zheng ZW; Wang QY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):102-4. PubMed ID: 23428122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lafutidine changes levels of somatostatin, calcitonin gene-related peptide, and secretin in human plasma.
    Itoh H; Naito T; Takeyama M
    Biol Pharm Bull; 2002 Mar; 25(3):379-82. PubMed ID: 11913538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells.
    Ju G; Hökfelt T; Brodin E; Fahrenkrug J; Fischer JA; Frey P; Elde RP; Brown JC
    Cell Tissue Res; 1987 Feb; 247(2):417-31. PubMed ID: 2434236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide and other neuropeptides in the plasma of patients with soft tissue injury.
    Onuoha GN; Alpar EK
    Life Sci; 1999; 65(13):1351-8. PubMed ID: 10503954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
    Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
    Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.